期刊文献+

黄斑水肿的治疗进展 被引量:7

下载PDF
导出
摘要 黄斑水肿是眼底疾病的常见并发症,可发生在糖尿病视网膜病变、视网膜静脉阻塞、葡萄膜炎以及白内障等多种眼前后段疾病和内眼手术后。因其损害中心视功能造成严重视力障碍,且尚无好的治疗方法而备受关注。黄斑水肿的病因各异,其治疗首先应治疗原发病;此外,针对黄斑水肿,除了传统的激光光凝等方法外,
出处 《实用防盲技术》 2008年第1期38-42,共5页 Journal of Practical Preventing Blind
  • 相关文献

参考文献14

  • 1林季建,张惠成,陈友慈,吴谟俊,吴有华.乙酰唑胺治疗黄斑囊样水肿的临床研究[J].中华眼底病杂志,1997,13(2):89-92. 被引量:9
  • 2魏欣,邓应平.循证医学与黄斑囊样水肿非类固醇抗炎药应用的选择[J].中国临床康复,2006,10(36):158-159. 被引量:2
  • 3黄渝侃,王智,张明昌.卵磷脂络合碘对CSC激光治疗后黄斑水肿吸收的影响[J].眼科研究,2006,24(5):546-548. 被引量:4
  • 4[5]Kobayashi H,Kobayashi K,Okinami S.Randomized clinical trial of topical betaxoloI for persistent macular edema after vitrectomv and epiretinal membrane removal.Am J Ophthalmol,2003.36:244251.
  • 5[9]Young jae cou,MD;In kyung oh,MD etc.intravitreal Versus posterior subtenon injection of triamcimolone acetonide for diabetic macular edema.Korean J Ophthalmol 2006,20:205-9.
  • 6[10]Nguyen QD,Tatlipilar S etc,Vascular endothelial growth factor is a critical stimulus for dialmtic macular edema.Am J Ophthalmol.2006,142:961-9.Epub 2006 Aug 2.
  • 7[11]Jorge R,Costa RA,Calucei D etc,intravitreal bevacizumab(Avastin)for persistent new vessels in diahetic Dretinopathy(IBEPE study),Retina,2006,26:1006-13.
  • 8[12]Haritoglou C,Kook D.Neubauer A etc,Intravitreal bevacizumab(Avastin)therapy for persistent diffuse diabetic macular edema,Retina 2006,26(9):1006-13.
  • 9[13]Spitzer MS,Youruek E.Sierra A etc.comparative antiproliferative and cytotoxic properties of bevacizumab(Avastin),pegaptanib(Macugen)and ranibizumab(Luccntis)on different ocular cells,Graefcs Arch Clin Exp Ophthalmol,2007,9.
  • 10[14]EUGENE W.M NG and ANTHONY P ADAMISantiVGEF Aptamer(Pegaptanip)Therapy for Ocular Vascular desease.Ann N Y Acad Sci.2006,1082:151-71.

二级参考文献27

  • 1李思江,林锦嘴主编.实用眼科病理学.北京:中国医药科技出版社,1997:253
  • 2Lewis H.The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol,2001,131:123.125
  • 3Ikeda T,Sato K,Katano T,et al.Visual acuity following pars plana vitrectomy for diabet cystoid macular edema and detached posterior hyaloid .Retina,2000,20:220-222
  • 4Gandorfer A.Messmer EM,Ulbig MW.et al .Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting merabrane .Retina ,2000,20:126-133
  • 5Scott D.Tarek S,George A,Morton S.vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior haliod.Am J Ophthalmol.2000,130:178-186
  • 6Tachi N,Hashimoto Y,Ogino N.Cystotomy for diabetic cystoid macular edema. Doc-Ophthalmol.1999,97(3-4):459-63
  • 7Gandorfer A ,Messmer EM,Ulbig MW,et al .Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane .Retina,2000 ,20:126-133
  • 8Martidis A,Dulker JS,Greenberg PB,et al. lntravitreal trimcinolone for refractory diabetic mscular edema [J].Ophthalmolgy 2002:109:920-927
  • 9Greenberg PB,Martidis A,Rogers AH,lntravitreal trimicinolone acetonide for macular edema due to central retinal vein occlusion[J].Br J Ophthalmol 2002,86:247-248
  • 10Ip MS,Gottlieb JL,Kahana A,et al.Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.Arch Ophthalmol,2004, 122(8 ): 1131 - 1136

共引文献16

同被引文献90

引证文献7

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部